Clinical Trial Update: Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a therapeutic HPV-16 vaccine for anal intraepithelial neoplasia in people with HIV has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Intraepithelial Neoplasia
• HIV Infection

Drugs mentioned

• Therapeutic HPV-16 vaccine

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Anal Intraepithelial Neoplasia, HIV | Phase 1, Phase 2 | Status: COMPLETED